2022 Annual Conference
Delirium is an acute neuropsychiatric problem that affects up to 50% of patients across the health care system and is associated with cognitive decline, increased mortality and a significant emotional and financial burden to patients, their families and society at large.
The American Delirium Society (ADS), now in its 11th year and on an impressive growth trajectory, seeks to foster research, education, quality improvement, patient-safety, advocacy and implement science to minimize the impact of delirium on patients across the health care spectrum. We are proud of the truly interdisciplinary nature of ADS, which brings together anesthesiologists, geriatricians, hospitalists, intensivists, internists, neurologists, nurses, pediatricians, pharmacists, physical and occupational therapists, psychiatrists, psychologists and surgeons under a single organization with the intent of raising awareness about the nature, consequences and management of delirium. Under the ADS umbrella, clinicians and researchers collaborate to promote understanding and foster research on the nature, prevention and treatment of this devastating syndrome.
The ADS 2022 Annual Conference will be held June 12-14, 2022 at The Westin Indianapolis – a large conference hotel located in the heart of Indianapolis, IN. The 2022 conference will be the largest ADS ever, with an expected attendance of close to 350 delirium-focused clinicians, researchers and administrators attending from around the world. Our final three-day scientific program will include more than 30 different sessions led by more than 100 of the top delirium experts in the world. Our interdisciplinary expert faculty, from more than 10 different countries, includes both clinical, translational and implementation science experts with expertise in surgery and peri-operative care, critical care, geriatrics, pediatric and palliative care. Our scientific abstracts submission attracted more than 100 submissions to the 2019 conference.
We applaud the mission of your company to improve delirium recognition and to help reduce its impact across the health care spectrum. This letter serves a dual purpose of providing the information regarding the 2022 ADS conference and is also an invitation to explore the ways in which your company can engage with our close to 350 expected attendees.
We hope your company is excited to partner with the American Delirium Society at our June 2022 Annual Conference in Indianapolis, IN!
Please feel free to get back to one of us if you would like to discuss any of these opportunities, or have other ideas. We look forward to partnering with you. Thank you for considering sponsoring the ADS’ scientific program. We hope to count on your support to tackle this disorder.